Drugs / Duvie
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06483243 | Apr 2024 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
| Phase 1 | NCT02685774 | Feb → Mar 2016 | type 2 diabetes mellitus | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Duvie | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06483243 ↗ |
| Route | Oral | “Duvie Tab. 0.5mg 1T, Glucophage XR Tab. 500mg 2T oral administration” NCT02685774 ↗ |